{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:05:38Z","timestamp":1787313938081,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1G1A109408"],"award-info":[{"award-number":["NRF-2019R1G1A109408"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Growing evidences shows that fasting glucose target should be different according to their health condition in older adults with diabetes. However, there are limited data regarding the relationship between fasting glucose level and health outcomes in Korean older people with diabetes. We aimed to examine the association of fasting glucose with mortality and cardiovascular events in Korean older adults with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From the Korean National Health Insurance System, 227,938 subjects (aged\u2009\u2265\u200965\u00a0years) with type 2 diabetes but no history of cardiovascular events (myocardial infarction or stroke) who underwent \u2265\u20092 health examinations from 2009 to 2010 and who were followed up until 2017 were identified. The primary exposure variable was the mean fasting glucose level. We estimated the relationship between the baseline fasting glucose level and incidences of all-cause death and cardiovascular events. Comorbidity load was assessed using the Charlson comorbidity index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fasting glucose levels and all-cause mortality risk showed a J-shaped relationship regardless of sex and number of comorbidities. Fasting glucose levels associated with the lowest mortality and cardiovascular events were 110\u2013124 and 95\u2013124\u00a0mg\/dL, respectively. Stratified analysis by comorbidity load using the Charlson comorbidity index revealed higher optimal fasting glucose levels for the lowest cardiovascular events in subjects with Charlson comorbidity index \u2265\u20093 than in those with Charlson comorbidity index\u2009\u2264\u20092 (119 vs. 112\u00a0mg\/dL, P\u2009=\u20090.04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>J-shaped relationship existed between fasting glucose and all-cause mortality and cardiovascular events in Korean older adults with diabetes. We identified that fasting glucose levels associated with the lowest mortality and cardiovascular events were 110\u2013124 and 95\u2013124\u00a0mg\/dL respectively. Increased risk of cardiovascular events with low fasting glucose level (&lt;\u200995\u00a0mg\/dL) was noted, especially in patients with high comorbidity. These findings suggested that less stringent targets of fasting glucose may be beneficial especially in older adults with multiple comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-020-01021-8","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T05:02:49Z","timestamp":1585717369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study"],"prefix":"10.1186","volume":"19","author":[{"given":"Ji Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-8007","authenticated-orcid":false,"given":"Ji Hye","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"1021_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012. JAMA. 2015;314:1021\u20139. https:\/\/doi.org\/10.1001\/jama.2015.10029.","journal-title":"JAMA"},{"key":"1021_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4093\/dmj.2018.0017","volume":"42","author":"JC Won","year":"2018","unstructured":"Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, et al. Diabetes fact sheet in Korea, 2016: an appraisal of current status. Diabetes Metab J. 2018;42:415\u201324. https:\/\/doi.org\/10.4093\/dmj.2018.0017.","journal-title":"Diabetes Metab J"},{"key":"1021_CR3","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg EW, Li Y, Wang J, Rios Burrows N, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990\u20132010. N Engl J Med. 2014;370:1514\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1310799.","journal-title":"N Engl J Med"},{"key":"1021_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/mlr.0b013e3181ca4035","volume":"48","author":"C Blaum","year":"2010","unstructured":"Blaum C, Cigolle CT, Boyd C, Wolff JL, Tian Z, Langa KM, et al. Clinical complexity in middle-aged and older adults with diabetes: the health and retirement study. Med Care. 2010;48:327\u201334. https:\/\/doi.org\/10.1097\/mlr.0b013e3181ca4035.","journal-title":"Med Care"},{"key":"1021_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2337\/dc10-2377","volume":"34","author":"ES Huang","year":"2011","unstructured":"Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34:1329\u201336. https:\/\/doi.org\/10.2337\/dc10-2377.","journal-title":"Diabetes Care"},{"key":"1021_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.diabet.2018.01.005","volume":"45","author":"SW Yi","year":"2019","unstructured":"Yi SW, Won YJ, Yi JJ. Low normal fasting glucose and risk of accidental death in Korean adults: a prospective cohort study. Diabetes Metab. 2019;45:60\u20136. https:\/\/doi.org\/10.1016\/j.diabet.2018.01.005.","journal-title":"Diabetes Metab"},{"issue":"Suppl 1","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.2337\/dc19s012","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. Older adults: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S139\u201347. https:\/\/doi.org\/10.2337\/dc19s012.","journal-title":"Diabetes Care"},{"key":"1021_CR8","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open. 2017;7:e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640.","journal-title":"BMJ Open"},{"key":"1021_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-11-1","volume":"11","author":"NF Khan","year":"2010","unstructured":"Khan NF, Perera R, Harper S, Rose PW. Adaptation and validation of the Charlson index for read\/OXMIS coded databases. BMC Fam Pract. 2010;11:1. https:\/\/doi.org\/10.1186\/1471-2296-11-1.","journal-title":"BMC Fam Pract"},{"key":"1021_CR10","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1093\/eurheartj\/ehx585","volume":"38","author":"MK Kim","year":"2017","unstructured":"Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, et al. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J. 2017;38:3560\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehx585.","journal-title":"Eur Heart J"},{"key":"1021_CR11","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36:4391\u2013400. https:\/\/doi.org\/10.1002\/sim.7501.","journal-title":"Stat Med"},{"key":"1021_CR12","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.2337\/dc12-1577","volume":"36","author":"C Park","year":"2013","unstructured":"Park C, Guallar E, Linton JA, Lee DC, Jang Y, Son DK, et al. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care. 2013;36:1988\u201393. https:\/\/doi.org\/10.2337\/dc12-1577.","journal-title":"Diabetes Care"},{"key":"1021_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2337\/dc17-1872","volume":"41","author":"SW Yi","year":"2018","unstructured":"Yi SW, Park S, Lee YH, Balkau B, Yi JJ. Fasting glucose and all-cause mortality by age in diabetes: a prospective cohort study. Diabetes Care. 2018;41:623\u20136. https:\/\/doi.org\/10.2337\/dc17-1872.","journal-title":"Diabetes Care"},{"key":"1021_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/01.cir.101.17.2047","volume":"101","author":"M Wei","year":"2000","unstructured":"Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation. 2000;101:2047\u201352. https:\/\/doi.org\/10.1161\/01.cir.101.17.2047.","journal-title":"Circulation"},{"key":"1021_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2337\/dc18-1390","volume":"42","author":"J Lu","year":"2019","unstructured":"Lu J, He J, Li M, Tang X, Hu R, Shi L, et al. Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults. Diabetes Care. 2019;42:1539\u201348. https:\/\/doi.org\/10.2337\/dc18-1390.","journal-title":"Diabetes Care"},{"key":"1021_CR16","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953. https:\/\/doi.org\/10.1136\/bmj.i5953.","journal-title":"BMJ"},{"key":"1021_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-018-0694-z","volume":"17","author":"G Lee","year":"2018","unstructured":"Lee G, Kim SM, Choi S, Kim K, Jeong SM, Son JS, et al. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study. Cardiovasc Diabetol. 2018;17:51. https:\/\/doi.org\/10.1186\/s12933-018-0694-z.","journal-title":"Cardiovasc Diabetol"},{"key":"1021_CR18","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545\u201359. https:\/\/doi.org\/10.1056\/NEJMoa0802743.","journal-title":"N Engl J Med"},{"key":"1021_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2337\/dc11-0996","volume":"35","author":"ER Seaquist","year":"2012","unstructured":"Seaquist ER, Miller ME, Bonds DE, Feinglos M, Goff DC Jr, Peterson K, et al. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care. 2012;35:409\u201314. https:\/\/doi.org\/10.2337\/dc11-0996.","journal-title":"Diabetes Care"},{"key":"1021_CR20","doi-asserted-by":"publisher","first-page":"f4533","DOI":"10.1136\/bmj.f4533","volume":"347","author":"A Goto","year":"2013","unstructured":"Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013;347:f4533. https:\/\/doi.org\/10.1136\/bmj.f4533.","journal-title":"BMJ"},{"key":"1021_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2337\/dc09-2082","volume":"33","author":"CV Desouza","year":"2010","unstructured":"Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389\u201394. https:\/\/doi.org\/10.2337\/dc09-2082.","journal-title":"Diabetes Care"},{"key":"1021_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/dmrr.865","volume":"24","author":"RJ Wright","year":"2008","unstructured":"Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:353\u201363. https:\/\/doi.org\/10.1002\/dmrr.865.","journal-title":"Diabetes Metab Res Rev"},{"key":"1021_CR23","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/jc.2010-3011","volume":"96","author":"JE Reusch","year":"2011","unstructured":"Reusch JE, Wang CC. Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab. 2011;96:2367\u201376. https:\/\/doi.org\/10.1210\/jc.2010-3011.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1021_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2337\/dc19-S006","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):61\u201370. https:\/\/doi.org\/10.2337\/dc19-S006.","journal-title":"Diabetes Care"},{"issue":"61","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","volume":"2018","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Management of Hyperglycaemia in Type 2 Diabetes, et al. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;2018(61):2461\u201398. https:\/\/doi.org\/10.1007\/s00125-018-4729-5.","journal-title":"Diabetologia"},{"key":"1021_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.diabres.2015.07.012","volume":"110","author":"MN Munshi","year":"2015","unstructured":"Munshi MN, Segal AR, Slyne C, Samur AA, Brooks KM, Horton ES. Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes. Diabetes Res Clin Pract. 2015;110:60\u20135. https:\/\/doi.org\/10.1016\/j.diabres.2015.07.012.","journal-title":"Diabetes Res Clin Pract"},{"key":"1021_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","volume":"17","author":"CRL Cardoso","year":"2018","unstructured":"Cardoso CRL, Leite NC, Moram CBM, Salles GF. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc Diabetol. 2018;17:33. https:\/\/doi.org\/10.1186\/s12933-018-0677-0.","journal-title":"Cardiovasc Diabetol"},{"key":"1021_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006757","author":"A Wang","year":"2017","unstructured":"Wang A, Liu X, Xu J, Han X, Su Z, Chen S, et al. Visit-to-visit variability of fasting plasma glucose and the risk of cardiovascular disease and all-cause mortality in the general population. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.117.006757.","journal-title":"J Am Heart Assoc"},{"key":"1021_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12933-019-0975-1","volume":"18","author":"RC Slieker","year":"2019","unstructured":"Slieker RC, van der Heijden A, Nijpels G, Elders PJM, t Hart LM, Beulens JWJ. Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort. Cardiovasc Diabetol. 2019;18:170. https:\/\/doi.org\/10.1186\/s12933-019-0975-1.","journal-title":"Cardiovasc Diabetol"},{"key":"1021_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/dc18-1430","volume":"42","author":"JB Echouffo-Tcheugui","year":"2019","unstructured":"Echouffo-Tcheugui JB, Zhao S, Brock G, Matsouaka RA, Kline D, Joseph JJ. Visit-to-visit glycemic variability and risks of cardiovascular events and all-cause mortality: the ALLHAT study. Diabetes Care. 2019;42:486\u201393. https:\/\/doi.org\/10.2337\/dc18-1430.","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-020-01021-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T19:10:38Z","timestamp":1617217838000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-020-01021-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1186\/s12933-020-01021-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Yonsei University Wonju College of Medicine (CR318331). Anonymous and de-identified information was used for analysis and, therefore, informed consent was not obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}